Cambridge Investment Research Advisors, Inc. Theratechnologies Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
$3.28 - $4.07 $33,226 - $41,229
-10,130 Closed
0 $0
Q2 2021

Aug 10, 2021
SELL
$3.43 - $3.96 $6,860 - $7,920
-2,000 Reduced 16.49%
10,130 $39,000
Q4 2020

Feb 04, 2021
SELL
$1.91 - $2.5 $6,881 - $9,007
-3,603 Reduced 22.9%
12,130 $30,000
Q3 2020

Oct 29, 2020
BUY
$1.96 - $2.92 $2,336 - $3,480
1,192 Added 8.2%
15,733 $34,000
Q1 2020

May 08, 2020
SELL
$1.43 - $3.23 $13,879 - $31,350
-9,706 Reduced 40.03%
14,541 $23,000
Q4 2019

Feb 04, 2020
BUY
$2.74 - $4.2 $66,436 - $101,837
24,247 New
24,247 $80,000

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0
View Full List

About Theratechnologies Inc.

THTX Quotes by TradingView
  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $114M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email